Pfizer Pushing For Pooling; W-L/AHP Court Decision Expected By Year-End
This article was originally published in The Tan Sheet
Executive Summary
Conditions of the proposed Warner-Lambert/American Home Products merger "do not serve a legitimate purpose," and were created to prevent a third party from making a counter bid for W-L, Pfizer charges.
You may also be interested in...
AmericanWarner Would House Nearly $5 Bil. Consumer Health Unit
Warner-Lambert's consumer products/OTC business would have a more natural home with American Home Products than with Pfizer.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands